Ramírez-Ponce B, Cervantes-García C, Reyes-Hernández U, Pérez-Ortiz M, Azamar-Cruz E, Reyes-Gómez U

Language: Spanish
References: 15
Page: 120-125
PDF size: 101.69 Kb.

ABSTRACT

We report the case of a 22-year-old female patient with a history of 2 fetal losses due to Cervical Incompetence. Cervical cerclage was made at the 10th week of her third pregnancy. At the 24th week of pregnancy, she was admitted to an emergency service for sepsis syndrome and fetal death, with sepsis of abdominopelvic origin. In an operating room the cerclage was removed and the dead fetus delivery was induced. She was admitted to an Intensive care unit, total abdominal hysterectomy and drainage was made 13 hours after, with subsequent abdominal lavage. She developed intravascular disseminated coagulation as part of multi-organic failure, which included: cardiovascular, lung, gastrointestinal, renal, liver and nervous system failure, barbituric coma was induced, the use of Recombinant Human Activated Protein C, was included and was discharged from the hospital two weeks later.
The association between stillbirth and cervical cerclage was considered the most important factor related to the obstetrical septic shock.
Patients with cervical cerclage need adecuate pregnant control, and they must be considered in the high-risk pregnancy group.

REFERENCES

1. 1.- Li XF, Fortney J A, Kotelchuck M, et al. The postpartum period: the key to maternal mortality. Int J Gynecol Obstet.2006; 54:1–10.

2. 2.- Khan KS, Wojdyla D, Say L, et al. WHO systematic review of causes of maternal deaths. Lancet 2006; 367: 1066–74.

3. 3.- Sepsis during pregnancy [Scientific Reviews] critical care medicine Volume 33(10) Supplement, October 2005, pp S286- S93.

4. 4.- Lash AF. Lash SR. Habitual abortion: incompetent internal of the cervix. Am J Obstet Gynecol.1950; 59:68-76.

5. 5.- Rush RW. Isaacs S. McPherson K. et al. A randomized controlled trial of cervical cerclage in women at high risk of spontaneous preterm delivery. Br J Obstet Gynecol.1984; 91: 724-30.

6. 6.- Ahued-Ahued R. Fernández del castillo C., Bailon-Uriza R. GinecologÍa y obstetricia aplicadas asociación mexicana de ginecologia y obstetricia. 2ª edición. México:Manual moderno;2001.p.305-12.

7. 7.- Dombrovskiy VY. Martin AA. Sunderram J. et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med. 2007; 35:1414–5.

8. 8.- Alfaro-Rodríguez H.Cejudo-Carranza E.Fiorelli-Rodríguez S. Complicaciones medicas durante el embarazo, 2a edición, México: Mc Graw Hill; 2004; p.314-22.

9. 9.- Fernandez CJ, Akamine N, DeMarco FVC, et al: Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 2001; 5: 362–567.

10. 10.- Corwin HL, Gettinger A, Pearl RG, et al: Efficacy of recombinant human erythropoietin in critically ill patients. JAMA 2002; 28: 2827-35.

11. 11.- Abdel-Wahab OI, Healy B, Dzik WH: Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46:1279-85.

12. 12.- Zannad F, Mebazaa A, Juilliere Y, et al: Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 2006; 8: 697–705.

13. 13.- Cariou A, Vinsonneau C, Dhainaut JF. Adjunctive therapies in sepsis: An evidence based review. Crit Care Med 2004; 32(11-Suppl): S562-S0.

14. 14.- Fourrier F. Recombinant human activated protein C on the treatment of severe sepsis: An evidence-based review. Crit Care Med 2004iik, m; 32(Suppl):S534-S41.

15. 15.- Manual de Atención embarazo saludable parto y puerperio seguros, recién nacido sano; Dirección General de Salud Reproductiva; Secretaría de Salud; 2001; 13-9.